Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 823486, 9 pages
http://dx.doi.org/10.1155/2010/823486
Research Article

Inflammatory Role of Toll-Like Receptors in Human and Murine Adipose Tissue

1CNRS 8199-Institute of Biology, Pasteur Institute, 59019 Lille, France
2INSERM U859, IFR114 IMPRT, Faculté de Médecine, Pôle Recherche, 59045 Lille, France
3Department of Endocrinology, Clínica Universitaria de Navarra, Universitaria de Navarra, Univ. Navarra, and CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, 31008 Pamplona, Spain
4Genomic Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK

Received 19 October 2009; Accepted 7 January 2010

Academic Editor: Oreste Gualillo

Copyright © 2010 Odile Poulain-Godefroy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Medzhitov and C. Janeway Jr., “The Toll receptor family and microbial recognition,” Trends in Microbiology, vol. 8, no. 10, pp. 452–456, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Aderem, “Role of Toll-like receptors in inflammatory response in macrophages,” Critical Care Medicine, vol. 29, no. 7, pp. S16–S18, 2001. View at Google Scholar · View at Scopus
  3. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, p. 783, 2006. View at Google Scholar
  4. D. Cook, D. Pisetsky, and D. Schwartz, “Toll-like receptors in the pathogenesis of human disease,” Nature Immunology, vol. 5, no. 10, pp. 975–979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Shi, M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. Flier, “TLR4 links innate immunity and fatty acid-induced insulin resistance,” Journal of Clinical Investigation, vol. 116, no. 11, pp. 3015–3025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Y. Lee, L. Zhao, H. S. Youn et al., “Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1,” Journal of Biological Chemistry, vol. 279, no. 17, pp. 16971–16979, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, p. 335, 2003. View at Google Scholar
  8. K. O. Omueti, J. M. Beyer, C. M. Johnson, E. A. Lyle, and R. I. Tapping, “Domain exchange between human Toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination,” Journal of Biological Chemistry, vol. 280, no. 44, pp. 36616–36625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Pålsson-McDermott and L. O'Neill, “The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases,” Irish Journal of Medical Science, vol. 176, no. 4, pp. 253–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Pouliot, J. Després, A. Nadeau et al., “Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels,” Diabetes, vol. 41, no. 7, pp. 826–834, 1992. View at Google Scholar
  11. V. Carey, E. Walters, G. Colditz et al., “Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women: the nurse's health stud,” American Journal of Epidemiology, vol. 145, no. 7, pp. 614–619, 1997. View at Google Scholar · View at Scopus
  12. O. Hamdy, S. Porramatikul, and E. Al-Ozairi, “Metabolic obesity: the paradox between visceral and subcutaneous fat,” Current Diabetes Reviews, vol. 2, no. 4, pp. 367–373, 2006. View at Google Scholar · View at Scopus
  13. M. Jensen, “Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model,” Obesity, vol. 14, pp. 20S–24S, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Poulain-Godefroy, C. Lecoeur, F. Pattou, G. Fruhbeck, and P. Froguel, “Inflammation is associated with a decrease of lipogenic factors in omental fat in women,” American Journal of Physiology, vol. 295, no. 1, pp. R1–R7, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Poulain-Godefroy and P. Froguel, “Preadipocyte response and impairment of differentiation in an inflammatory environment,” Biochemical and Biophysical Research Communications, vol. 356, no. 3, pp. 662–667, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Gregoire, C. Smas, and H. Sul, “Understanding adipocyte differentiation,” Physiological Reviews, vol. 78, no. 3, pp. 783–809, 1998. View at Google Scholar · View at Scopus
  17. G. Thompson, D. Trainor, C. Biswas, C. LaCerte, J. Berger, and L. Kelly, “A high-capacity assay for PPARgamma ligand regulation of endogenous aP2 expression in 3T3-L1 cells,” Analytical Biochemistry, vol. 330, no. 1, pp. 21–28, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Meng, M. Rutz, M. Schiemann et al., “Antagonistic antibody prevents Toll-like receptor 2-driven lethal shock-like syndromes,” Journal of Clinical Investigation, vol. 113, no. 10, pp. 1473–1481, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Zhang, S.-H. Wang, M. E. Lasbury et al., “Toll-like receptor 2 mediates alveolar macrophage response to pneumocystis murina,” Infection and Immunity, vol. 74, no. 3, pp. 1857–1864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. E. D. Rosen, C. J. Walkey, P. Puigserver, and B. M. Spiegelman, “Transcriptional regulation of adipogenesis,” Genes and Development, vol. 14, no. 11, pp. 1293–1307, 2000. View at Google Scholar · View at Scopus
  21. S. Shoelson, L. Herrero, and A. Naaz, “Obesity, inflammation, and insulin resistance,” Journal of Gastroenterology, vol. 132, p. 2169, 2007. View at Google Scholar
  22. S. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. Leibel, and A. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Fantuzzi, “Adipose tissue, adipokines, and inflammation,” Journal of Allergy and Clinical Immunology, vol. 115, no. 5, pp. 911–920, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Fontana, J. Eagon, M. Trujillo, P. Scherer, and S. Klein, “Visceral fat adipokine secretion is associated with systemic inflammation in obese humans,” Diabetes, vol. 56, no. 4, pp. 1010–1013, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. L. Tsukumo, M. A. Carvalho-Filho, J. B. C. Carvalheira et al., “Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance,” Diabetes, vol. 56, no. 8, pp. 1986–1998, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Harman-Boehm, M. Büher, H. Redel et al., “Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 6, pp. 2240–2247, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H.-M. Zhang, L.-L. Chen, L. Wang et al., “Macrophage infiltrates with high levels of Toll-like receptor 4 expression in white adipose tissues of male Chinese,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 10, pp. 736–743, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Lin, H. Lee, A. H. Berg, M. P. Lisanti, L. Shapiro, and P. Scherer, “The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes,” Journal of Biological Chemistry, vol. 275, no. 32, pp. 24255–24263, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Zarember and P. Godowski, “Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines,” Journal of Immunology, vol. 168, no. 2, pp. 554–561, 2002. View at Google Scholar · View at Scopus
  30. P. Cani, J. Amar, M. Iglesias et al., “Metabolic endotoxemia initiates obesity and insulin resistance,” Diabetes, vol. 56, no. 7, pp. 1761–1772, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Tarkowski, J. Bjersing, A. Shestakov, and M. I. Bokarewa, “Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4,” Journal of Cellular and Molecular Medicine. In press, September 2009.
  32. I. Rifkin, E. Leadbetter, L. Busconi, G. Viglianti, and A. Marshak-Rothstein, “Toll-like receptors, endogenous ligands, and systemic autoimmune disease,” Immunological Reviews, vol. 204, pp. 27–42, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Kopp, C. Buechler, M. Neumeier et al., “Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes,” Obesity, vol. 14, no. 4, pp. 648–656, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Fain, S. Bahouth, and A. Madan, “TNFalpha release by the nonfat cells of human adipose tissue,” International Journal of Obesity, vol. 28, no. 4, pp. 616–622, 2004. View at Publisher · View at Google Scholar · View at Scopus